Loading clinical trials...
Loading clinical trials...
Investigation of Phenotypes, Endotypes and Immune Response Features in Allergic Airway Diseases
This study aims to investigate immune mechanisms and phenotypes and endotypes of allergic airway diseases - allergic rhinitis and allergic asthma. Pathogenesis of these diseases are not fully investigated yet. Patients with the same disease have different dominant symptoms, course of the disease and response to treatment. Moreover, there is a hypothesis about united airway disease suggesting that allergic rhinitis and allergic asthma is different manifestation of the same disease. This led to assumption of phenotypes and endotypes. This classification which still is not unified can let to prescribe personalized treatment for every patient.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Hospital of Lithuanian University of Health Sciences Kauno klinikos
Kaunas, Lithuania
Start Date
May 1, 2019
Primary Completion Date
November 1, 2022
Completion Date
April 1, 2024
Last Updated
April 17, 2020
150
ESTIMATED participants
Nasal provocation test
PROCEDURE
Lead Sponsor
Lithuanian University of Health Sciences
NCT05008965
NCT06732414
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05494346